Skip to main content
Clinical Trials/NCT01826630
NCT01826630TerminatedNot Applicable

A Double-Blind Pilot Study To Assess The Feasibility of a Larger Study to Assess The Efficacy of A Novel Gel Wash Cleanser Formulated With Sodium Hypochlorite To Reduce Skin Fauna In Patients With Chronic Hand Dermatitis/Atopic Dermatitis.

Shari L Hand2 sites in 1 country4 target enrollmentStarted: July 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
4
Locations
2
Primary Endpoint
Change in Amount of Skin Fauna

Study Overview

Brief Summary

The primary objective of this protocol is to acquire pilot data for a larger study to test the following hypothesis: Treatment of the hands of patients with chronic hand dermatitis/atopic dermatitis with CLn BodyWash, a novel gel wash cleanser currently marketed as a cosmetic product containing a dilute concentration of less than 0.01% sodium hypochlorite and less than 0.005% concentration as it is lathered, will result in a statistically significant reduction in the number of skin fauna present on the hands of these patients compared to treatment of such patients with traditional wash used clinically such as Cetaphil Daily Facial Cleanser.

Detailed Description

Patients with Hand Eczema will be asked to wash with either a CLn BodyWash or Cetaphil Daily Facial Cleanser. Patients and study staff will be blinded. Hand swabs will be done prior to the wash and after 20 minutes. The average time spent in the study for each patient should be less than 2 hours unless an Adverse Event occurs.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Seen by an OSU Dermatology provider at OSU Dermatology East after the date of approval of this protocol
  • Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
  • Willingness to participate in a research study.
  • Diagnosis of chronic hand dermatitis

Exclusion Criteria

  • Inability to provide informed consent
  • Allergy to any of the treatments used

Arms & Interventions

CLn BodyWash

Active Comparator

CLn BodyWash will be used to wash hands of patients with Hand Atopic Dermatitis

Intervention: CLn BodyWash (Other)

Cetaphil Daily Facial Cleanser

Active Comparator

Cetaphil Daily Facial Cleanser will be used to wash hands of patients with Hand Atopic Dermatitis

Intervention: Cetaphil Daily Facial Cleanser (Other)

Outcomes

Primary Outcomes

Change in Amount of Skin Fauna

Time Frame: one wash

Mean Decrease in Fauna after Washing with either CLn BodyWash or Cetaphil Daily Facial Cleanser.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Shari L Hand
Sponsor Class
Industry
Responsible Party
Sponsor Investigator
Principal Investigator

Shari L Hand

Clinical Research Director

TopMD Skin Care, Inc.

Study Sites (2)

Loading locations...

Similar Trials